$CTCX
Carmell Corp

2023 Q4 Form 10-Q Financial Statement

#000095017023063884 Filed on November 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue $0.00 $3.729M $0.00
YoY Change
Cost Of Revenue $1.544M
YoY Change
Gross Profit $2.185M
YoY Change
Gross Profit Margin 58.6%
Selling, General & Admin $2.623M $4.495M $706.6K
YoY Change 271.21% 3528.56% 91.02%
% of Gross Profit 205.71%
Research & Development $2.497M $1.672M
YoY Change 192.84%
% of Gross Profit 76.52%
Depreciation & Amortization -$382.7K $429.5K
YoY Change 1718.35%
% of Gross Profit 19.66%
Operating Expenses $5.217M $7.322M $706.6K
YoY Change 638.37% 5811.33% 91.02%
Operating Profit -$5.137M
YoY Change 4047.32%
Interest Expense -$26.83K $4.314M $1.336M
YoY Change -102.01% 517.74% 24467.83%
% of Operating Profit
Other Income/Expense, Net -$10.23M -$6.327M
YoY Change 21.32%
Pretax Income -$16.21M -$11.46M $629.9K
YoY Change -2672.71% -2095.91% -368.61%
Income Tax $0.00 $0.00 $391.2K
% Of Pretax Income 62.11%
Net Earnings -$16.12M -$11.46M $238.7K
YoY Change -6853.99% -1463.52% -201.79%
Net Earnings / Revenue -307.46%
Basic Earnings Per Share -$0.62
Diluted Earnings Per Share -$1.46 -$0.62 $0.01
COMMON SHARES
Basic Shares Outstanding 23.08M 19.24M
Diluted Shares Outstanding 18.63M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.912M $7.969M $187.7K
YoY Change 1451.99% 2014.61% -75.76%
Cash & Equivalents $2.912M $7.968M $187.7K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $97.54K
YoY Change -100.0% -100.0% -50.98%
Inventory $0.00 $9.808M $0.00
Prepaid Expenses $761.3K $1.312M $97.54K
Receivables $14.40M
Other Receivables $0.00
Total Short-Term Assets $62.90M $38.87M $285.2K
YoY Change 21954.58% 7246.72% -70.69%
LONG-TERM ASSETS
Property, Plant & Equipment $192.8K $289.8K $255.0K
YoY Change -24.37%
Goodwill $19.31M $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments $156.7M
YoY Change 1.45%
Other Assets
YoY Change
Total Long-Term Assets $1.049M $43.35M $156.7M
YoY Change -99.33% -72.09% 1.45%
TOTAL ASSETS
Total Short-Term Assets $62.90M $38.87M $285.2K
Total Long-Term Assets $1.049M $43.35M $156.7M
Total Assets $63.95M $82.22M $157.0M
YoY Change -59.26% -47.25% 1.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.417M $17.79M $2.139M
YoY Change 106.54%
Accrued Expenses $2.921M $3.856M $1.258M
YoY Change 132.17% 373.28% 484.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $5.610M $0.00
YoY Change
Long-Term Debt Due $1.289M $1.721M
YoY Change
Total Short-Term Liabilities $38.50M $37.71M $1.682M
YoY Change 2189.73% 4439.03% 409.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.498M $0.00
YoY Change
Other Long-Term Liabilities $697.7K $14.26M $5.405M
YoY Change -87.09% 163.84% 0.0%
Total Long-Term Liabilities $697.7K $15.76M $5.405M
YoY Change -87.09% 191.55% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $38.50M $37.71M $1.682M
Total Long-Term Liabilities $697.7K $15.76M $5.405M
Total Liabilities $39.20M $61.31M $7.087M
YoY Change 453.13% 883.07% 23.56%
SHAREHOLDERS EQUITY
Retained Earnings -$58.50M -$61.66M -$6.018M
YoY Change 872.12% 1047.76% 26.36%
Common Stock $2.309K $2.308K $894.00
YoY Change 158.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.75M $20.92M -$6.018M
YoY Change
Total Liabilities & Shareholders Equity $63.95M $82.22M $157.0M
YoY Change -59.26% -47.25% 1.0%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income -$16.12M -$11.46M $238.7K
YoY Change -6853.99% -1463.52% -201.79%
Depreciation, Depletion And Amortization -$382.7K $429.5K
YoY Change 1718.35%
Cash From Operating Activities -$3.144M -$5.204M -$189.2K
YoY Change 1562.31% 4871.62% 166.69%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $30.47K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $663.0K $0.00
YoY Change
Cash From Investing Activities -$663.0K $632.5K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.249M 12.41M 0.000
YoY Change -17830.89% -100.0%
NET CHANGE
Cash From Operating Activities -3.144M -5.204M -189.2K
Cash From Investing Activities -663.0K 632.5K 0.000
Cash From Financing Activities -1.249M 12.41M 0.000
Net Change In Cash -5.056M 7.840M -189.2K
YoY Change 2572.9% -4588.67% 150.68%
FREE CASH FLOW
Cash From Operating Activities -$3.144M -$5.204M -$189.2K
Capital Expenditures $0.00 $30.47K
Free Cash Flow -$3.144M -$5.234M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001842939
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2019 2020 2021 2022
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40228
dei Entity Registrant Name
EntityRegistrantName
CARMELL CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1645738
dei Entity Address Address Line1
EntityAddressAddressLine1
2403 Sidney Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsburgh
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15203
dei City Area Code
CityAreaCode
919
dei Local Phone Number
LocalPhoneNumber
313-9633
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
CTCX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23081642
CY2023Q3 us-gaap Cash
Cash
7968502
CY2022Q4 us-gaap Cash
Cash
128149
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
14404800
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
0
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1311593
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
55069
CY2023Q3 us-gaap Inventory Net
InventoryNet
9808235
CY2022Q4 us-gaap Inventory Net
InventoryNet
0
CY2023Q3 ctcx Forward Purchase Agreement
ForwardPurchaseAgreement
5376139
CY2022Q4 ctcx Forward Purchase Agreement
ForwardPurchaseAgreement
0
CY2023Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
0
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
394147
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
0
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
28175
CY2023Q3 us-gaap Assets Current
AssetsCurrent
38869269
CY2022Q4 us-gaap Assets Current
AssetsCurrent
605540
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
772028
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
530116
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
289800
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
254974
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
865006
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
859331
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
444403
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
42044
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22886343
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28702
CY2023Q3 us-gaap Goodwill
Goodwill
19313527
CY2022Q4 us-gaap Goodwill
Goodwill
0
CY2023Q3 us-gaap Assets
Assets
82223945
CY2022Q4 us-gaap Assets
Assets
1748547
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
17790349
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2138732
CY2023Q3 ctcx Accrued Expenses And Other Liabilities Excluding Interest Payable Current
AccruedExpensesAndOtherLiabilitiesExcludingInterestPayableCurrent
2307797
CY2022Q4 ctcx Accrued Expenses And Other Liabilities Excluding Interest Payable Current
AccruedExpensesAndOtherLiabilitiesExcludingInterestPayableCurrent
944573
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
140825
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
129502
CY2023Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
8000000
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
0
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
732567
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2777778
CY2023Q3 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
0
CY2022Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
826980
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
37709927
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7295285
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
741186
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
827728
CY2023Q3 ctcx Contingent Earnout Liabilities
ContingentEarnoutLiabilities
13520385
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7836876
CY2023Q3 us-gaap Liabilities
Liabilities
61306374
CY2022Q4 us-gaap Liabilities
Liabilities
8123013
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
1
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23081642
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23081642
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
894318
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
894318
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2308
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
894
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82576012
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4590858
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61660750
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42382291
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
20917571
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-37790539
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82223945
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1748547
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3728816
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3728816
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1543826
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1543826
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2023Q3 us-gaap Gross Profit
GrossProfit
2184990
CY2022Q3 us-gaap Gross Profit
GrossProfit
0
us-gaap Gross Profit
GrossProfit
2184990
us-gaap Gross Profit
GrossProfit
0
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1671906
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
570935
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3235888
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1554602
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3069520
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3069520
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0
CY2023Q3 ctcx Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
1425180
CY2022Q3 ctcx Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
257369
ctcx Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
2573082
ctcx Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
1094399
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
429477
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23619
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
479848
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70638
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
726280
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Restructuring Charges
RestructuringCharges
726280
us-gaap Restructuring Charges
RestructuringCharges
0
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7322363
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
851923
us-gaap Operating Expenses
OperatingExpenses
10084618
us-gaap Operating Expenses
OperatingExpenses
2719639
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5137373
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-851923
us-gaap Operating Income Loss
OperatingIncomeLoss
-7899628
us-gaap Operating Income Loss
OperatingIncomeLoss
-2719639
CY2023Q3 us-gaap Other Income
OtherIncome
3683
CY2022Q3 us-gaap Other Income
OtherIncome
9
us-gaap Other Income
OtherIncome
37763
us-gaap Other Income
OtherIncome
10883
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14179
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
606420
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
22479
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2044241
CY2023Q3 ctcx Loss On Forward Purchase Agreement
LossOnForwardPurchaseAgreement
10592442
CY2022Q3 ctcx Loss On Forward Purchase Agreement
LossOnForwardPurchaseAgreement
0
ctcx Loss On Forward Purchase Agreement
LossOnForwardPurchaseAgreement
10592442
ctcx Loss On Forward Purchase Agreement
LossOnForwardPurchaseAgreement
0
CY2023Q3 ctcx Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
-38093
CY2022Q3 ctcx Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
0
ctcx Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
-38093
ctcx Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
0
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
4697138
CY2022Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2658328
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
826980
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1259287
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1064692
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1064692
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6327396
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5215379
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10702808
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3216475
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11464769
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6067302
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18602436
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5936114
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-11464769
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6067302
us-gaap Net Income Loss
NetIncomeLoss
-18602436
us-gaap Net Income Loss
NetIncomeLoss
-5936114
CY2023Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
49378
CY2022Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
94190
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
676023
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
248152
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11514147
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6161492
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19278459
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6184266
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.74
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.74
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18629730
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18629730
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
913655
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
913655
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6871258
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6871258
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1651593
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1651593
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-45106381
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15195
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
237760
CY2023Q3 ctcx Stock Issued During Period Value Convertible Noteholders Upon Merger
StockIssuedDuringPeriodValueConvertibleNoteholdersUponMerger
250000
CY2023Q3 ctcx Stock Issued During Period Value Business Combination Net Of Transaction Costs
StockIssuedDuringPeriodValueBusinessCombinationNetOfTransactionCosts
55382355
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
21652790
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-11464769
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
20917571
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-28821777
CY2022Q3 ctcx Stock Issued During Period Value Exercise Of Common Stock Warrants
StockIssuedDuringPeriodValueExerciseOfCommonStockWarrants
16659
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1511
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
106951
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6067302
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-34769115
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-37790539
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41064
ctcx Stock Issued During Period Value Convertible Noteholders Upon Merger
StockIssuedDuringPeriodValueConvertibleNoteholdersUponMerger
250000
ctcx Stock Issued During Period Value Business Combination Net Of Transaction Costs
StockIssuedDuringPeriodValueBusinessCombinationNetOfTransactionCosts
55382355
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
21652790
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
605299
us-gaap Net Income Loss
NetIncomeLoss
-18602436
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
20917571
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-29577046
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
26477
ctcx Stock Issued During Period Value Exercise Of Common Stock Purchase Warrants
StockIssuedDuringPeriodValueExerciseOfCommonStockPurchaseWarrants
16659
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2294
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
449817
us-gaap Net Income Loss
NetIncomeLoss
-5936114
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-34769115
us-gaap Profit Loss
ProfitLoss
-18602436
us-gaap Profit Loss
ProfitLoss
-5936114
us-gaap Share Based Compensation
ShareBasedCompensation
605299
us-gaap Share Based Compensation
ShareBasedCompensation
476294
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
479848
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70638
ctcx Operating Lease Right Of Use Asset Amortization Expense Reversal
OperatingLeaseRightOfUseAssetAmortizationExpenseReversal
-5675
ctcx Operating Lease Right Of Use Asset Amortization Expense Reversal
OperatingLeaseRightOfUseAssetAmortizationExpenseReversal
112331
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
22479
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2044241
ctcx Change In Fair Value Of Forward Purchase Agreement
ChangeInFairValueOfForwardPurchaseAgreement
10592442
ctcx Change In Fair Value Of Forward Purchase Agreement
ChangeInFairValueOfForwardPurchaseAgreement
0
ctcx Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
-38093
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
826980
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1259287
us-gaap Paid In Kind Interest
PaidInKindInterest
250000
us-gaap Paid In Kind Interest
PaidInKindInterest
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1064692
ctcx Interest Recognized Upon Default
InterestRecognizedUponDefault
0
ctcx Interest Recognized Upon Default
InterestRecognizedUponDefault
555556
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3891200
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1039646
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
11888
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1606890
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-0
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-28184
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
18175
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1464049
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
957688
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2111480
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
729592
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-75219
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-94045
ctcx Increase Decrease In Accrued Interest Payable Related And Third Party
IncreaseDecreaseInAccruedInterestPayableRelatedAndThirdParty
1831014
ctcx Increase Decrease In Accrued Interest Payable Related And Third Party
IncreaseDecreaseInAccruedInterestPayableRelatedAndThirdParty
178938
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-423754
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5203790
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1129539
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30470
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3579
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
662997
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
632527
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3579
ctcx Proceeds From Merger
ProceedsFromMerger
31050882
ctcx Proceeds From Merger
ProceedsFromMerger
0
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
248174
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0
ctcx Cash Transferred In Connection With Forward Purchase Agreement
CashTransferredInConnectionWithForwardPurchaseAgreement
17535632
ctcx Cash Transferred In Connection With Forward Purchase Agreement
CashTransferredInConnectionWithForwardPurchaseAgreement
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41064
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2197140
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
us-gaap Repayments Of Debt
RepaymentsOfDebt
443791
us-gaap Repayments Of Debt
RepaymentsOfDebt
0
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2649873
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2745974
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
226817
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2294
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
382222
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1561285
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
104641
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12411616
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1131631
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7840353
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1487
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
128149
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12362
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7968502
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10875
us-gaap Interest Paid Net
InterestPaidNet
11367
us-gaap Interest Paid Net
InterestPaidNet
92593
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
423754
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
ctcx Assets Acquired In Acquisition Net
AssetsAcquiredInAcquisitionNet
42472084
ctcx Assets Acquired In Acquisition Net
AssetsAcquiredInAcquisitionNet
0
ctcx Earnout Liability And Deferred Consideration Payable Incurred In Connection With Acquisition
EarnoutLiabilityAndDeferredConsiderationPayableIncurredInConnectionWithAcquisition
21482292
ctcx Earnout Liability And Deferred Consideration Payable Incurred In Connection With Acquisition
EarnoutLiabilityAndDeferredConsiderationPayableIncurredInConnectionWithAcquisition
0
ctcx Issuance Of Series A Preferred Stock And Common Stock In Connection With Acquisition
IssuanceOfSeriesAPreferredStockAndCommonStockInConnectionWithAcquisition
21652789
ctcx Issuance Of Series A Preferred Stock And Common Stock In Connection With Acquisition
IssuanceOfSeriesAPreferredStockAndCommonStockInConnectionWithAcquisition
0
ctcx Accrued Series A Preferred Stock Dividends
AccruedSeriesAPreferredStockDividends
164510
ctcx Accrued Series A Preferred Stock Dividends
AccruedSeriesAPreferredStockDividends
230943
ctcx Accrued Series C1 Preferred Stock Dividends
AccruedSeriesC1PreferredStockDividends
40551
ctcx Accrued Series C1 Preferred Stock Dividends
AccruedSeriesC1PreferredStockDividends
304
ctcx Accrued Series C2 Preferred Stock Dividends
AccruedSeriesC2PreferredStockDividends
470962
ctcx Accrued Series C2 Preferred Stock Dividends
AccruedSeriesC2PreferredStockDividends
16906
ctcx Debt Discount Recorded In Connection With Loans Payable
DebtDiscountRecordedInConnectionWithLoansPayable
55062
ctcx Debt Discount Recorded In Connection With Loans Payable
DebtDiscountRecordedInConnectionWithLoansPayable
0
ctcx Unpaid Transaction Costs Incurred In Connection With Business Combinations
UnpaidTransactionCostsIncurredInConnectionWithBusinessCombinations
1186219
ctcx Unpaid Transaction Costs Incurred In Connection With Business Combinations
UnpaidTransactionCostsIncurredInConnectionWithBusinessCombinations
0
ctcx Unpaid Liabilities Assumed In Connection With Merger
UnpaidLiabilitiesAssumedInConnectionWithMerger
6179562
ctcx Unpaid Liabilities Assumed In Connection With Merger
UnpaidLiabilitiesAssumedInConnectionWithMerger
0
ctcx Conversion Of Common Stock And Preferred Stock In Connection With Merger
ConversionOfCommonStockAndPreferredStockInConnectionWithMerger
32093004
ctcx Conversion Of Common Stock And Preferred Stock In Connection With Merger
ConversionOfCommonStockAndPreferredStockInConnectionWithMerger
0
ctcx Conversion Of Convertible Notes And Accrued Notes To Series C2 Preferred Stock
ConversionOfConvertibleNotesAndAccruedNotesToSeriesC2PreferredStock
0
ctcx Conversion Of Convertible Notes And Accrued Notes To Series C2 Preferred Stock
ConversionOfConvertibleNotesAndAccruedNotesToSeriesC2PreferredStock
15665172
ctcx Warrants Issued In Connection With Convertible Notes
WarrantsIssuedInConnectionWithConvertibleNotes
0
ctcx Warrants Issued In Connection With Convertible Notes
WarrantsIssuedInConnectionWithConvertibleNotes
409483
ctcx Warrants Issued In Connection With Series C1 Preferred Stock
WarrantsIssuedInConnectionWithSeriesC1PreferredStock
0
ctcx Warrants Issued In Connection With Series C1 Preferred Stock
WarrantsIssuedInConnectionWithSeriesC1PreferredStock
92055
ctcx Initial Recognition Of Derivative Liabilities
InitialRecognitionOfDerivativeLiabilities
0
ctcx Initial Recognition Of Derivative Liabilities
InitialRecognitionOfDerivativeLiabilities
1321860
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19305129
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.28
CY2023Q3 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
29374372
CY2023Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
29376282
CY2023Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.28
CY2023Q3 ctcx Termination Fee Payable Per Share
TerminationFeePayablePerShare
0.5
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates in these financial statements include those related to the forward purchase asset, earnout liabilities, derivative liabilities, long-term assets and goodwill impairment. the provision or benefit for income taxes and the corresponding valuation allowance on deferred tax assets and contingent liabilities. If the underlying estimates and assumptions upon which the financial statements are based change in the future, actual amounts may differ from those included in the accompanying financial statements.</span></p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
7968502
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
30000
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2022Q4 ctcx Capitalized Offering Costs Writeoff
CapitalizedOfferingCostsWriteoff
1278062
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1317369
us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
1581070
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
368784
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
The Company has elected to apply the significant financing practical expedient, as allowed under ASC 606. As a result, the Company does not adjust the promised amount of consideration in a customer contract for the effects of a significant financing component when the period of time between when we transfer a promised good or service to a customer and when the customer pays for the good or service will be one year or less.
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company has standard payment terms that generally require payment within approximately 60-120 days.
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
211085
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
1250
us-gaap Advertising Expense
AdvertisingExpense
211356
us-gaap Advertising Expense
AdvertisingExpense
3552
us-gaap Depreciation
Depreciation
48118
us-gaap Depreciation
Depreciation
44780
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2023Q3 us-gaap Goodwill
Goodwill
19313527
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10433330
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17639113
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations</span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the nine months ended September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customer accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of revenues. In addition, this customer accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of accounts receivable at September 30, 2023. The Company's human amnion allograft product made up </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the Company's revenue for the nine months ended September 30, 2023. For the nine months ended September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the Company's human amnion allograft product was purchased from Pinnacle Transplant Technologies, LLC.</span></p>
CY2023Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
70746
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7968046
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
128149
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5137373
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-851923
us-gaap Operating Income Loss
OperatingIncomeLoss
-7899628
us-gaap Operating Income Loss
OperatingIncomeLoss
-2719639
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5203790
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1129539
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61660750
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42382291
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1061828
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
785090
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
772028
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
530116
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
289800
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
254974
CY2022Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
70746
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23330746
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
444403
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22886343
CY2022Q4 ctcx Capitalized Patent Costs Included In Intangible Assets
CapitalizedPatentCostsIncludedInIntangibleAssets
28702
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
402000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
402000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
601846
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2657948
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2693124
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2729451
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2703997
CY2023Q3 ctcx Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
11499977
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22886343
CY2023Q3 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
1328813
CY2022Q4 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
916934
CY2023Q3 ctcx Accrued Severance
AccruedSeverance
703947
CY2023Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
275037
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
27639
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2307797
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
944573
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
446127
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6918147
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
13168
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
45713
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
47457
CY2023Q3 ctcx Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
1893662
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
9364274
us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
The Company has 401(k) profit-sharing plans covering substantially all employees. The Company’s discretionary profit-sharing contributions are determined annually by the Board. No discretionary profit-sharing contributions were made to the plans during the nine months ended September 30, 2023 and 2022.
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19236305
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
ctcx Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
0.199
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4638444
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.2
ctcx Warant Weighted Average Remaining Lease Term
WarantWeightedAverageRemainingLeaseTerm
P4Y9M7D
us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
258953
ctcx Warrants Outstanding Expiry
WarrantsOutstandingExpiry
February and June of 2028
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2235313
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.22
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y25D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1083492
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
344631
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.91
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
23420
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1004638
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.33
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1551886
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.15
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M8D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2252300
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1224773
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y8M19D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1904182
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.82
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0355
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0375
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
223560
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
277634
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
591102
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
449817
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1769600
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P6Y7M6D
CY2023Q3 ctcx Payable To Related Party
PayableToRelatedParty
11670
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
0000950170-23-063884-index-headers.html Edgar Link pending
0000950170-23-063884-index.html Edgar Link pending
0000950170-23-063884.txt Edgar Link pending
0000950170-23-063884-xbrl.zip Edgar Link pending
ctcx-20230930.htm Edgar Link pending
ctcx-20230930.xsd Edgar Link pending
ctcx-ex31_1.htm Edgar Link pending
ctcx-ex31_2.htm Edgar Link pending
ctcx-ex32_1.htm Edgar Link pending
ctcx-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
ctcx-20230930_cal.xml Edgar Link unprocessable
ctcx-20230930_def.xml Edgar Link unprocessable
ctcx-20230930_lab.xml Edgar Link unprocessable
ctcx-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ctcx-20230930_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending